{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-145153","form_type":"8-K","ticker":"VCNX","cik":"0001205922","company_name":"VACCINEX, INC.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.171184+00:00","generated_at":"2026-06-15T00:42:32.259220+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vaccinex raises ~$2.96M via private placement of 7.9M shares at $0.37428","bullets":["Sold 7,908,516 shares at $0.37428/share for $2.96M gross proceeds; closed May 15, 2023.","Proceeds to fund pepinemab development in cancer/neurodegenerative disease and working capital.","FCMI Parent Co., controlled by chairman Albert D. Friedberg, participated in the offering.","Shares unregistered; exempt under Rule 506 and Section 4(a)(2); registration rights granted to other investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-145153","json":"https://secwatch.observer/filing/0001193125-23-145153.json","markdown":"https://secwatch.observer/filing/0001193125-23-145153.md","text":"https://secwatch.observer/filing/0001193125-23-145153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1205922/000119312523145153/0001193125-23-145153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1205922/000119312523145153/d464446d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T00:42:32.259220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"42a6a977a49e5da463279d3aa8db367deeeeff3e","claim":"VACCINEX, INC. entered into Stock Purchase Agreement with certain accredited investors valued at approximately $2.96 million (effective 2023-05-12).","evidence_excerpt":"On May 12, 2023, Vaccinex, Inc. (the “Company”) entered into a stock purchase agreement (the “Stock Purchase Agreement”) pursuant to which the Company agreed to issue and sell 7,908,516 shares of common stock of the Company (the “Shares”) at a purchase price of $0.37428 per Share for aggregate gross proceeds of approximately $2.96 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1205922/000119312523145153/0001193125-23-145153-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"approximately $2.96 million"},{"label":"Effective","value":"2023-05-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}